Cargando…
Mesenchymal stem cells modified to express lentivirus TNF-α Tumstatin(45–132) inhibit the growth of prostate cancer
Mesenchymal stem cells (MSCs) are a potential novel delivery system for cell-based gene therapies. Although tumour necrosis factor (TNF)-α has been shown to have antitumour activity, its use in therapy is limited by its systemic toxicity. For the present study, we designed lentivirus-mediated signal...
Autores principales: | Zhang, Xu, Xu, Wenrong, Qian, Hui, Zhu, Wei, Zhang, Ruiwen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Blackwell Publishing Ltd
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3822807/ https://www.ncbi.nlm.nih.gov/pubmed/19799647 http://dx.doi.org/10.1111/j.1582-4934.2009.00920.x |
Ejemplares similares
-
Downregulation of tumstatin expression by overexpression of ornithine decarboxylase
por: WANG, WEI, et al.
Publicado: (2013) -
Experimental study of a novel tumstatin on C6 brain glioma in vitro
por: Zhang, Pengguo, et al.
Publicado: (2017) -
Mesenchymal stem cells genetically modified by lentivirus-mediated interleukin-12 inhibit malignant ascites in mice
por: HAN, JIMING, et al.
Publicado: (2014) -
Improved therapeutics of modified mesenchymal stem cells: an update
por: Ocansey, Dickson Kofi Wiredu, et al.
Publicado: (2020) -
Tumstatin regulates the angiogenic and inflammatory potential of airway smooth muscle extracellular matrix
por: Harkness, Louise Margaret, et al.
Publicado: (2017)